Literature DB >> 17993614

Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia.

Jun Yang1, P K Epling-Burnette, Jeffrey S Painter, Jianxiang Zou, Fanqi Bai, Sheng Wei, Thomas P Loughran.   

Abstract

Clonal T-cell expansion in patients with T-large-granular lymphocyte (LGL) leukemia occurs by an undefined mechanism that may be related to Fas apoptosis resistance. Here, we demonstrate polarized expansion of CD8(+) terminal-memory differentiation in such patients, as demonstrated by CD45RA expression and absence of CD62L expression, suggesting repeated stimulation by antigen in vivo. Elimination of antigen-stimulated T cells normally occurs through Fas-mediated apoptosis. We show that cells from LGL leukemia patients express increased levels of c-FLIP and display resistance to Fas-mediated apoptosis and abridged recruitment of proteins that comprise the death-inducing signaling complex (DISC), including the Fas-associated protein with death-domain (FADD) and caspase-8. Exposure to interleukin-2 (IL-2) for only 24 hours sensitized leukemic LGL to Fas-mediated apoptosis with enhanced formation of the DISC, and increased caspase-8 and caspase-3 activities. We observed dysregulation of c-FLIP by IL-2 in leukemic LGL, suggesting a role in Fas resistance. Our results demonstrate that expanded T cells in patients with LGL leukemia display both functional and phenotypic characteristics of prior antigen activation in vivo and display reduced capacity for Fas-mediated DISC formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17993614      PMCID: PMC2214759          DOI: 10.1182/blood-2007-06-093823

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Homeostatic control of T-cell generation in neonates.

Authors:  Stefan O Schönland; Julia K Zimmer; Consuelo M Lopez-Benitez; Thomas Widmann; Kirk D Ramin; Jörg J Goronzy; Cornelia M Weyand
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

2.  Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor.

Authors:  H J Yoon; K Sugamura; T P Loughran
Journal:  Leukemia       Date:  1990-12       Impact factor: 11.528

3.  FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells.

Authors:  Maria Rita Rippo; Simona Moretti; Silvia Vescovi; Marco Tomasetti; Sara Orecchia; Giuseppe Amici; Alfonso Catalano; Antonio Procopio
Journal:  Oncogene       Date:  2004-10-14       Impact factor: 9.867

Review 4.  Clonal diseases of large granular lymphocytes.

Authors:  T P Loughran
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

5.  Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.

Authors:  Gudrun Strauss; Ingrid Knape; Ingo Melzner; Klaus-Michael Debatin
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

Review 6.  Survival signals in leukemic large granular lymphocytes.

Authors:  P K Epling-Burnette; Thomas P Loughran
Journal:  Semin Hematol       Date:  2003-07       Impact factor: 3.851

7.  Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia.

Authors:  G Starkebaum; T P Loughran; V S Kalyanaraman; M E Kadin; P G Kidd; J W Singer; F W Ruscetti
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

8.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

9.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

10.  The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice.

Authors:  G G Singer; A K Abbas
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

View more
  31 in total

1.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.

Authors:  Adam W Mailloux; Ling Zhang; Lynn Moscinski; John M Bennett; Lili Yang; Sean J Yoder; Gregory Bloom; Cody Wei; Sheng Wei; Lubomir Sokol; Thomas P Loughran; Pearlie K Epling-Burnette
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

3.  A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.

Authors:  Akihiko Yokohama; Anjali Mishra; Takeki Mitsui; Brian Becknell; Jessica Johns; Douglas Curphey; Bradley W Blaser; Jeffrey B Vandeusen; Hsiaoyin Mao; Jianhua Yu; Michael A Caligiuri
Journal:  Leuk Res       Date:  2009-08-05       Impact factor: 3.156

4.  Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.

Authors:  Renato Zambello; Gianpietro Semenzato
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

5.  Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia.

Authors:  Michael J Clemente; Marcin W Wlodarski; Hideki Makishima; Aaron D Viny; Isabell Bretschneider; Mohammad Shaik; Nelli Bejanyan; Alan E Lichtin; Eric D Hsi; Eric D His; Ronald L Paquette; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2011-08-24       Impact factor: 22.113

Review 6.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

7.  The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.

Authors:  Hanna L M Rajala; Thomas Olson; Michael J Clemente; Sonja Lagström; Pekka Ellonen; Tuija Lundan; David E Hamm; Syed Arshi Uz Zaman; Jesus M Lopez Marti; Emma I Andersson; Andres Jerez; Kimmo Porkka; Jaroslaw P Maciejewski; Thomas P Loughran; Satu Mustjoki
Journal:  Haematologica       Date:  2014-10-03       Impact factor: 9.941

Review 8.  Never say die: survival signaling in large granular lymphocyte leukemia.

Authors:  Mithun Vinod Shah; Ranran Zhang; Thomas P Loughran
Journal:  Clin Lymphoma Myeloma       Date:  2009

9.  Network model of survival signaling in large granular lymphocyte leukemia.

Authors:  Ranran Zhang; Mithun Vinod Shah; Jun Yang; Susan B Nyland; Xin Liu; Jong K Yun; Réka Albert; Thomas P Loughran
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

10.  Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway.

Authors:  Jun Yang; Xin Liu; Susan B Nyland; Ranran Zhang; Lindsay K Ryland; Kathleen Broeg; Kendall Thomas Baab; Nancy Ruth Jarbadan; Rosalyn Irby; Thomas P Loughran
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.